E. Cadman

发表

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1994, The Journal of pharmacology and experimental therapeutics.

Regulation of the Release of Interleukin‐6 from Human Astrocytoma Cells

E. Cadman, Chi-Ming Lee, C. Lee, 1994, Journal of neurochemistry.

cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells

E. Cadman, Chi-Ming Lee, Darren D. Naugles, 1994, Neuroscience Letters.

Beta-amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro.

E. Cadman, P. Puttfarcken, 1997, Experimental neurology.

Renal failure secondary to leukemic infiltration of the kidneys.

E. Cadman, W. B. Lundberg, S. Finch, 1977, The American journal of medicine.

The Presence of the Complement Cascade Does Not Lead to Neuronal Cell Death in Primary Hippocampal Cultures

E. Cadman, P. Puttfarcken, K. Shiosaki, 1997, Brain Research Bulletin.

Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors.

D. Anderson, E. Cadman, D. Garvey, 1992, Journal of medicinal chemistry.

Involvement of a cytoplasmic protein in calcium-dependent potassium efflux in red blood cells.

E. Cadman, G. Plishker, P. H. White, 1986, The American journal of physiology.

Aminopyridazine muscarinic agonist, SR 95639A, is a functional M2 receptor antagonist in rat brain

E. Cadman, M. Williams, M. Decker, 1991 .

Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.

E. Cadman, T. Vickroy, 1989, Journal of Pharmacology and Experimental Therapeutics.

β-Amyloid Peptides Initiate the Complement Cascade without Producing a Comparable Effect on the Terminal Pathwayin Vitro

E. Cadman, P. Puttfarcken, 1997, Experimental Neurology.

Effects of chlorisondamine on nicotinic receptor binding in whole brain and nicotine‐induced changes in locomotor activity in rats

S. Arneric, E. Cadman, M. Decker, 1994 .